[go: up one dir, main page]

CA3280389A1 - Antisense oligonucleotides for rna editing and methods for using the same - Google Patents

Antisense oligonucleotides for rna editing and methods for using the same

Info

Publication number
CA3280389A1
CA3280389A1 CA3280389A CA3280389A CA3280389A1 CA 3280389 A1 CA3280389 A1 CA 3280389A1 CA 3280389 A CA3280389 A CA 3280389A CA 3280389 A CA3280389 A CA 3280389A CA 3280389 A1 CA3280389 A1 CA 3280389A1
Authority
CA
Canada
Prior art keywords
methods
same
antisense oligonucleotides
rna editing
editing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3280389A
Other languages
French (fr)
Inventor
Riccardo Pecori
Annette Arnold
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of CA3280389A1 publication Critical patent/CA3280389A1/en
Pending legal-status Critical Current

Links

CA3280389A 2023-01-18 2024-01-17 Antisense oligonucleotides for rna editing and methods for using the same Pending CA3280389A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23152263.2 2023-01-18

Publications (1)

Publication Number Publication Date
CA3280389A1 true CA3280389A1 (en) 2024-07-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP4177345A4 (en) Improved rna editing method
GB202011428D0 (en) Antisense oligonucleotides for RNA editing
CA3262119A1 (en) Oligonucleotides for adar-mediated rna editing and use thereof
EP4149485A4 (en) Rna formulations for high volume distribution, and methods of using the same for treating covid-19
AU2003290597A1 (en) Modified oligonucleotides for use in rna interference
EP3940078A4 (en) Off-target single nucleotide variants caused by single-base editing and high-specificity off-target-free single-base gene editing tool
AU2003299864A1 (en) Sirna compounds and methods for the downregulation of gene expression
EP4004207A4 (en) Oligonucleotide antagonists for rna guided genome editing
AU2003250196A1 (en) Method for preparing oligonucleotides
CA3263686A1 (en) Rna for preventing or treating tuberculosis
AU2003215262A1 (en) Method for generating amplified rna
WO2005001039A3 (en) Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
AU2003304565A1 (en) Film-forming composition suitable for hard capsules and method for preparing the same
CA3280389A1 (en) Antisense oligonucleotides for rna editing and methods for using the same
IL320984A (en) Chemically modified antisense oligonucleotides (asos) and compositions comprising the same for rna editing
PL1663997T3 (en) 1h-azolyl-methyl-amides, method for the production thereof and use thereof as nitrification inhibitors
CA3286000A1 (en) Chemically modified antisense oligonucleotides for use in rna editing
CA3274363A1 (en) Chemically modified antisense oligonucleotides (asos) and compositions comprising the same for rna editing
AU2003218507A1 (en) Methods for treating rosacea with pyridones
CA3285442A1 (en) Guide rna and use method thereof
CA3271182A1 (en) Compositions and methods comprising programmable snrnas for rna editing
CA3298803A1 (en) Chemically modified antisense oligonucleotides (asos) and compositions for rna editing
AU2024325709A1 (en) Chemically modified antisense oligonucleotides (asos) and compositions for rna editing
CA3284435A1 (en) Rna